Equifax insider plans sale of 1,167 shares

Equifax insider Jamil Farshchi has filed a notice to sell company stock.

Accepted by SEC EDGAR 02/11/2026 - 09:56 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Equifax insider Jamil Farshchi has filed a notice to sell company stock. The filing covers a planned sale of 1,167 shares of common stock on the NYSE through Fidelity Brokerage Services, with an approximate sale date of 02/11/2026 and an aggregate market value of 233,248.29.

The 1,167 shares were acquired on 02/10/2026 through restricted stock vesting as compensation from the issuer. The notice also shows that on 02/10/2026, Farshchi sold 6,213 common shares for gross proceeds of 1,216,567.53.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for EFX disclose about Jamil Farshchi?

The Form 144 shows that insider Jamil Farshchi plans to sell 1,167 Equifax common shares and recently sold 6,213 shares. These transactions reflect sales of vested restricted stock and are disclosed to comply with Rule 144 reporting requirements for insider share sales.

How many Equifax (EFX) shares is the insider planning to sell under this Form 144?

The insider plans to sell 1,167 Equifax common shares. The filing lists these shares with an aggregate market value of 233,248.29, to be sold on the NYSE through Fidelity Brokerage Services, with an approximate sale date of 02/11/2026 under Rule 144.

How were the Equifax (EFX) shares in the Form 144 acquired by the insider?

The 1,167 Equifax shares were acquired on 02/10/2026 through restricted stock vesting. The filing describes the nature of the transaction as compensation from the issuer, indicating these shares were part of the insider’s equity-based pay rather than an open-market purchase.

What recent Equifax (EFX) stock sales by the insider are disclosed in the filing?

The filing reports that on 02/10/2026 the insider sold 6,213 Equifax common shares. These shares generated gross proceeds of 1,216,567.53. This disclosure covers securities sold during the past three months, as required by Rule 144 aggregation rules for affiliated sellers.

On which exchange will the Equifax (EFX) Form 144 shares be sold?

The planned 1,167-share sale is listed for the NYSE. The filing identifies Fidelity Brokerage Services as the broker and specifies the NYSE as the securities exchange where the common shares are expected to be sold, consistent with standard Rule 144 secondary market transactions.

What is the reported market value of the Equifax (EFX) shares to be sold?

The Form 144 indicates an aggregate market value of 233,248.29 for the 1,167 Equifax shares. This figure reflects the estimated total value of the planned sale at the time of the notice and helps quantify the size of the transaction relative to typical insider activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001732980
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EQUIFAX INC
SEC File Number	001-06605
Address of Issuer	1550 PEACHTREE ST NW ATLANTA GEORGIA 30302
Phone	4048858000
Name of Person for Whose Account the Securities are To Be Sold	Farshchi Jamil
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1167	233248.29	122394037	02/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Restricted Stock Vesting	Issuer			1167	02/10/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jamil Farshchi 1550 Peachtree Street N.W. Atlanta GA 30309	Common	02/10/2026	6213	1216567.53

144: Remarks and Signature

Remarks
Date of Notice	02/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	04/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jamil Farshchi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)